Advertisement

Topics

cell pharm GmbH Company Profile

00:30 EDT 23rd October 2017 | BioPortfolio

Nil

Contact

Email: info@cellpharm.com


News Articles [1347 Associated News Articles listed on BioPortfolio]

R-Pharm out-licenses molecule for design of anti-cancer drugs to Aspyrian

R-Pharm, one of Russia’s leading drugmakers, has signed an agreement with the USA’s clinical stage…

TR-PHARM Sees Early Success In Mediterranean Fever Antibody

TR-PHARM, a Turkish affiliate of the leading Russian pharma company R-PHARM, has disclosed promising early results for clinical trials with...   

Molecular Devices and Cytena Partner collaborate in single cell printing

Molecular Devices, LLC announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This system utilizes microfluidics-based technology and real-time ...

R-Pharm considers expanding in Japanese pharmaceutical market

R-Pharm, one of Russia’s leading biotech firms, is considering expanding into the Japanese pharmaceutical…

Zydus and Pharm Aid enter deal for varicella vaccine technology in Russia

Indian healthcare company Zydus Cadila has entered an exclusive agreement with Pharm Aid for the technology expertise of varicella vaccine production in Russia to prevent chickenpox.

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Experts in pharma education stress on the need to update syllabus of pharmacy education in every two─three years

Experts in pharmacy education are of the view that syllabus of B Pharm and D Pharm should be updated at least every second or third year, as one of the major criticisms about Indian pharmacy education...

Lee's Pharm and SillaJen Approved for China Immunotherapy Trial

Lee's Pharm received CFDA approval for a Phase III trial of Pexa-Vec in patients with advanced liver cancer. The study is part of the PHOCUS global trial that was started in 2015. Lee's Pharm owns Chi...

PubMed Articles [2642 Associated PubMed Articles listed on BioPortfolio]

Corrigendum to "Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line" Eur. J. Pharm. Biopharm. 119 (2017) 253-263.

Corrigendum to "Comparative tissue distribution and excretion study of alkaloids from Herba Ephedrae-Radix Aconiti Lateralis extracts in rats" J. Pharm. Biomed. Anal., 134 (2017) 137-142.

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Lineage Tracing: Papers and Progress.

This i3 is a data visualization based on the Cell Stem Cell tenth anniversary theme of lineage tracing. Using Scopus citations of Cell Stem Cell research papers, it illustrates both the evolution of t...

Clinical Trials [5306 Associated Clinical Trials listed on BioPortfolio]

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

This open-label, Phase I study will evaluate the safety, tolerability, and pharm acokinetics of increasing doses of GDC-0853 in patients with relapsed or refract ory B-cell non-Hodgkin's l...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Rivaroxaban from Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Indust...

Vaccination Education Through Pharmacists and Senior Centers (VEPSC)

The study consists of two arms (PHARM and PEER) designed to educate participants about three vaccine-preventable diseases (zoster, pneumonia, and influenza) and vaccination. PHARM will con...

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

Belotecan (Camtobell, CKD-602, Chong Kun Dang Pharm., Korea) is a new camptothecin derivative, that exhibits anticancer effects by inhibiting topoisomerase I. The investigators will have a...

Companies [1482 Associated Companies listed on BioPortfolio]

cell pharm GmbH

Nil

Pharm PlanNet Contract Research GmbH

Pharm PlanNet Contract Research GmbH (Pharm PlanNet) was founded in 1992 as an independent and privately owned Clinical Research Organisation offering its service to the pharmaceutical industry. Pharm...

Pharm-Olam International Ltd.

Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology...

NP Pharm

Founded in January 1992, NP Pharm is a private company, part of the Pharmaceutical group ETHYPHARM, which is one of the world leading companies for Drug Delivery Systems (DDS). Based, on a large exper...

Beijing Med-Pharm Corp

Beijing Med-Pharm offers an end-to-end solution to U.S and western pharmaceutical companies wishing to sell their products in China. We offer sales and marketing services throughout China and can help...

More Information about "cell pharm GmbH" on BioPortfolio

We have published hundreds of cell pharm GmbH news stories on BioPortfolio along with dozens of cell pharm GmbH Clinical Trials and PubMed Articles about cell pharm GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of cell pharm GmbH Companies in our database. You can also find out about relevant cell pharm GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record